Effects of Different Therapeutic Schedules on Patients with COVID-19: A Prospective Case–Control Study in China

Figure 2

Progression of COVID-19 patients in WM treatment and TCM-WM treatment (a) The proportion of patients with severe type. (b) The proportion of patients with critically ill. (c) Time from admission to severe. (d) Average stay. (e) Time of nucleic acid turning negative. (f) Nucleic acid test positive 14 days after discharge. (g) Injury ratio of liver and kidney.

(a)

(b)

(c)

(d)

(e)

(f)

(g)